<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Gorchs L</submitter><funding>Cancerföreningen i Stockholm (Cancer Society in Stockholm)</funding><funding>Insamlingsstiftelsen Cancer- och Allergifonden (Cancer and Allergy Fund)</funding><funding>Insamlingsstiftelsen Cancer- och Allergifonden</funding><funding>Swedish Cancer Foundation</funding><funding>Ruth och Richard Julins Stiftelse (Ruth and Richard Julin Foundation)</funding><funding>Cancerföreningen i Stockholm</funding><funding>Ruth och Richard Julins Stiftelse</funding><pagination>460-474</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10875982</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>4(2)</volume><pubmed_abstract>In pancreatic ductal adenocarcinoma, the infiltration of CD8+ T cells within the tumor microenvironment correlates with a favorable prognosis. However, a significant proportion of tumor-infiltrating T cells become trapped within the desmoplastic stroma and lack tumor reactivity. Here, we explored different T-cell subsets in pancreatic tumors and adjacent tissues. We identified a subset of CD8+ T cells, double positive (DP) for CD39 and CD103 in pancreatic tumors, which has recently been described to display tumor reactivity in other types of solid tumors. Interestingly, DP CD8+ T cells preferentially accumulated in central tumor tissues compared with paired peripheral tumor and adjacent non-tumor tissues. Consistent with an antigen encounter, DP CD8+ T cells demonstrated higher proliferati</pubmed_abstract><journal>Cancer research communications</journal><pubmed_title>Exhausted Tumor-infiltrating CD39+CD103+ CD8+ T Cells Unveil Potential for Increased Survival in Human Pancreatic Cancer.</pubmed_title><pmcid>PMC10875982</pmcid><funding_grant_id>10679</funding_grant_id><funding_grant_id>20 1162 PjF</funding_grant_id><funding_grant_id>2022-00285</funding_grant_id><funding_grant_id>221173</funding_grant_id><funding_grant_id>201152</funding_grant_id><funding_grant_id>10388</funding_grant_id><pubmed_authors>Lohr MJ</pubmed_authors><pubmed_authors>Asplund E</pubmed_authors><pubmed_authors>Gorchs L</pubmed_authors><pubmed_authors>Solders M</pubmed_authors><pubmed_authors>Sparrelid E</pubmed_authors><pubmed_authors>Kaipe H</pubmed_authors><pubmed_authors>Ghorbani P</pubmed_authors><pubmed_authors>Oosthoek M</pubmed_authors><pubmed_authors>Fernandez-Moro C</pubmed_authors><pubmed_authors>Rangelova E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Exhausted Tumor-infiltrating CD39+CD103+ CD8+ T Cells Unveil Potential for Increased Survival in Human Pancreatic Cancer.</name><description>In pancreatic ductal adenocarcinoma, the infiltration of CD8+ T cells within the tumor microenvironment correlates with a favorable prognosis. However, a significant proportion of tumor-infiltrating T cells become trapped within the desmoplastic stroma and lack tumor reactivity. Here, we explored different T-cell subsets in pancreatic tumors and adjacent tissues. We identified a subset of CD8+ T cells, double positive (DP) for CD39 and CD103 in pancreatic tumors, which has recently been described to display tumor reactivity in other types of solid tumors. Interestingly, DP CD8+ T cells preferentially accumulated in central tumor tissues compared with paired peripheral tumor and adjacent non-tumor tissues. Consistent with an antigen encounter, DP CD8+ T cells demonstrated higher proliferati</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Feb</publication><modification>2026-05-29T12:11:01.044Z</modification><creation>2025-04-04T14:00:59.058Z</creation></dates><accession>S-EPMC10875982</accession><cross_references><pubmed>38335302</pubmed><doi>10.1158/2767-9764.CRC-23-0405</doi></cross_references></HashMap>